Cambria Investment Management L.P. Reduces Holdings in Tenet Healthcare Corporation $THC

Cambria Investment Management L.P. lessened its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 6.3% in the third quarter, Holdings Channel reports. The institutional investor owned 73,883 shares of the company’s stock after selling 4,956 shares during the period. Tenet Healthcare accounts for approximately 0.9% of Cambria Investment Management L.P.’s portfolio, making the stock its 7th biggest position. Cambria Investment Management L.P.’s holdings in Tenet Healthcare were worth $15,001,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently modified their holdings of the stock. Triumph Capital Management purchased a new position in shares of Tenet Healthcare in the 3rd quarter worth about $25,000. William B. Walkup & Associates Inc. purchased a new stake in Tenet Healthcare during the 3rd quarter valued at about $32,000. Canada Pension Plan Investment Board bought a new stake in Tenet Healthcare during the 2nd quarter valued at about $35,000. Westside Investment Management Inc. raised its holdings in Tenet Healthcare by 100.0% in the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after buying an additional 96 shares during the last quarter. Finally, Trust Co. of Vermont purchased a new stake in shares of Tenet Healthcare during the third quarter valued at approximately $41,000. 95.44% of the stock is owned by hedge funds and other institutional investors.

Tenet Healthcare Stock Performance

Shares of THC opened at $211.88 on Wednesday. Tenet Healthcare Corporation has a one year low of $109.82 and a one year high of $247.21. The business has a fifty day moving average of $213.78 and a 200 day moving average of $204.75. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The firm has a market capitalization of $18.42 billion, a P/E ratio of 13.68, a PEG ratio of 1.06 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. During the same period last year, the firm posted $3.44 earnings per share. The business’s revenue for the quarter was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, sell-side analysts anticipate that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts recently weighed in on THC shares. TD Cowen restated a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Wall Street Zen raised Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Sunday, March 1st. Wells Fargo & Company reaffirmed an “overweight” rating and set a $265.00 price target on shares of Tenet Healthcare in a report on Monday, February 16th. Truist Financial boosted their target price on Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Finally, Royal Bank Of Canada raised their price target on shares of Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a report on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $250.56.

Insider Activity at Tenet Healthcare

In other news, EVP Thomas W. Arnst sold 8,000 shares of the business’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the completion of the sale, the executive vice president owned 12 shares of the company’s stock, valued at $2,866.20. The trade was a 99.85% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider R. Scott Ramsey sold 8,017 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 46,517 shares of company stock worth $10,943,111. 0.81% of the stock is owned by company insiders.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.